Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06346483 · ClinicalTrials.gov registry record · NA
Ureteroscopy With High-powered Holmium:Yag Laser Lithotripsy With and Moses On or Moses Off
A NA study of Kidney Stone and Ureteral Stone, sponsored by Northwestern University.
- Recruiting
- Registry status
- NA
- Development phase
- 150
- Enrollment target
- 1
- Study location
NCT06346483: Recruiting NA study of Kidney Stone and Ureteral Stone, sponsored by Northwestern University.
NCT06346483 is a NA study of Kidney Stone and Ureteral Stone that is actively recruiting participants, run by Northwestern University. The registered enrollment target is 150 participants, below the 188-participant average among 28 other Kidney Stone trials with a reported enrollment target (20% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06346483, a NA study of Kidney Stone and Ureteral Stone, is actively recruiting participants, sponsored by Northwestern University.
- RECRUITING
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to compare Moses 2.0 pulse modulation technology and the standard high powered Holmium Laser lithotripsy and how it will affect time in the operating room, time using the laser, laser energy, and stone free rates. Currently Moses 2.0 laser technology is FDA approved and currently used in practice since 2021. No study to this date has compared Moses 2.0 without pulse modulation laser technology to Moses 2.0 with pulse modulation laser technology. The study will be including kidney and ureteral stones (a kidney stone located in the tube between the kidney and the bladder) that are 6mm and greater, but less than 20 mm in size undergoing ureteroscopic treatment. High powered lasers are used for "dusting". Dusting is when a laser is used to break a stone down into tiny fragments that are able to pass through the urine.
Primary Outcome
Total amount of time (in minutes) taken to complete the procedure.
Conditions Studied
Interventions
- PROCEDURE Dusting without Moses 2.0 Modulation
- PROCEDURE Dusting with Moses 2.0 Modulation
- OTHER Moses 2.0 Modulation
Study Locations (1)
Illinois
- Northwestern Medicine - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2023-06-09 |
| Est. Completion | 2026-06-09 |
| Phase | NA |
What NCT06346483 shows while recruiting
NCT06346483 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 188-participant average among 28 other Kidney Stone trials with a reported enrollment target (20% lower).
The record links to 2 conditions, with Kidney Stone appearing as the primary indexed condition, and to 3 interventions - of which Dusting without Moses 2.0 Modulation is the first listed.
NCT06346483 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT06346483 about?
NCT06346483 is a clinical study titled "Ureteroscopy With High-powered Holmium:Yag Laser Lithotripsy With and Moses On or Moses Off". The purpose of this study is to compare Moses 2.0 pulse modulation technology and the standard high powered Holmium Laser lithotripsy and how it will affect time in the operating room, time using the laser, laser energy, and stone free rates. Currently Moses 2.0 laser technology is FDA approved and...
What is the current status of trial NCT06346483?
This trial is currently recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2023-06-09. Estimated completion is 2026-06-09.
What conditions does trial NCT06346483 study?
This clinical trial studies the following conditions: Kidney Stone, Ureteral Stone.
What interventions are being tested in trial NCT06346483?
The interventions under investigation include: Dusting without Moses 2.0 Modulation (PROCEDURE), Dusting with Moses 2.0 Modulation (PROCEDURE), Moses 2.0 Modulation (OTHER).
Who is sponsoring clinical trial NCT06346483?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06346483 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Kidney Stone
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06346483's enrollment target sits among peer trials
150 5th of 28 higher than 23 of 28 other Kidney Stone trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Kidney Stone trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Oxalate and Citrate in Humans - Response to Citrate
RECRUITING · NA
-
Gut Oxalate Absorption in Calcium Oxalate Stone Disease
RECRUITING · NA
-
High Powered Stone Dusting vs. Fragmentation and Basketing at Time of Ureteroscopy
RECRUITING · NA
-
Access Sheath and Stent Trial
RECRUITING · NA
-
GI Oxalate Absorption
RECRUITING · NA
-
Evaluation of the LithoVue Elite Ureteroscope With Intra-Renal Pressure Monitoring Technology: Examination of Surgeon Behavior and Post-operative Outcomes
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI